Cargando…

OSA Wellness Scale (OWS): A New Health-Related Quality of Life Test in Obstructive Sleep Apnea Patients Treated with Mandibular Advancement Device

OBJECTIVES: To present a new short self-test, called the OSA wellness scale (OWS), for assessing the health-related quality of life (HRQoL) changes in obstructive apnea syndrome (OSA) patients treated with mandibular advancement device (MAD). METHODS: 51 OSA patients (8 women and 43 men, mean age 52...

Descripción completa

Detalles Bibliográficos
Autores principales: Ciavarella, Domenico, Campobasso, Alessandra, Guida, Laura, Cazzolla, Angela Pia, Montaruli, Graziano, Corlianò, Fabrizio, Romano, Luigi, Cassano, Michele, Tepedino, Michele, Burlon, Giuseppe
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9519331/
https://www.ncbi.nlm.nih.gov/pubmed/36187733
http://dx.doi.org/10.1155/2022/4629341
Descripción
Sumario:OBJECTIVES: To present a new short self-test, called the OSA wellness scale (OWS), for assessing the health-related quality of life (HRQoL) changes in obstructive apnea syndrome (OSA) patients treated with mandibular advancement device (MAD). METHODS: 51 OSA patients (8 women and 43 men, mean age 52.3) treated with a fully customizable MAD device (Protrusor) were retrospectively enrolled. Each patient received a home sleep apnea testing (HSAT) at baseline (T0) and after three months of MAD treatment (T1). Two self-test evaluations, the Epworth sleepiness scale (ESS), and OWS were also submitted at T0 and T1. The OWS was a short self-test of 8 questions for evaluating the daytime HRQoL. Patients gave an assessment from 0 to 3 for each question. At the end of the questionnaire, the patients had a score from 0 to 24, resulting from the sum of all 8 scores. The higher the score, the greater the patient's perceived state of discomfort. RESULTS: At T1, a significant decrease in the oxygen desaturation index (ODI) and apnea-hypopnea index (AHI) was shown (p < 0.0001), while no significant changes in body mass index (BMI) were found. Both the ESS and the OWS records showed a significant reduction in daytime sleepiness and HRQoL (p < 0.0001). CONCLUSION: The OWS could be a useful method to verify and numerically compare the perceived quality of life in OSA patients, before and after MAD therapy.